Status:
COMPLETED
Electronic Pill Bottle Monitoring to Promote Medication Adherence for People With Multiple Sclerosis
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Multiple Sclerosis Society
Pillsy, Inc.
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
People with multiple sclerosis (MS) have variable adherence to MS medications, making the full efficacy of disease modifying therapies unrealized and the assessment of true treatment failures challeng...
Detailed Description
The investigators will enroll 85 adult patients, 18 years old and above, with relapsing remitting multiple sclerosis (RRMS), at the Massachusetts General Hospital MS Clinics in a pilot study of Pillsy...
Eligibility Criteria
Inclusion
- Ability to provide individual written consent
- Ability to understand sufficient levels of English to use the Pillsy app
- Ability to come to Massachusetts General Hospital for two study visits over a 90-day window OR ability to access Zoom for virtual study visits
- Possess a smartphone
- Willingness to follow the study protocol
Exclusion
- Presence of an MS relapse requiring acute management and/or hospitalization
- Daily medication provided by allied health care workers
- Foreign travel preventing electronic remote monitoring
- Expectation of discontinuation of the oral disease modifying therapy (DMT) in the upcoming 90 days for any reason
Key Trial Info
Start Date :
November 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 26 2021
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT04130256
Start Date
November 15 2019
End Date
January 26 2021
Last Update
July 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114